Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Celebrity endorsements of prescription drugs

Richard Meyer
Meds
July 27, 2011
Share
Tweet
Share

Boniva continues to use Sally Field as a celebrity spokesperson for their product but as John Mack pointed out, should any prescription drugs be paying celebrities to endorse their products?  Well, according to an Ace Metrix study the answer to that is “probably no.”

The Ace Metrix study found of more than 2,600 ads that celebrity ads do not perform any better than non-celebrity ads and in some case perform much worse.  In their study whether or not a celebrity endorses a product was unimportant in determining whether an ad resonated with viewers.  In fact compared with industry norms relatively few celebrity ads were able to earn performance marks above the industry averages.

So given the costs of celebrity endorsements, sometimes way over $10 million, there is a greater chance for a better ROI for DTC marketers who focus on creative content in ads and aspects of the ad that grab attention and demonstrate relevance.   In fact give me a budget of half of what you pay a celebrity and I will demonstrate a hell of a lot better ROI via the Internet, including “intent” to ask their physician for the product.

The other key issue when it comes to celebrity endorsements is “should drug companies pay millions of dollars to a celebrity at a time when people are having a hard time with medication co-pays?”  For example less than ten percent of the nation’s 38 million elderly people are living in poverty, according to official statistics. But once medical care and other costs of living are factored in, the number of people 65 and older living in poverty jumps to 16.1 percent, according to a new Census Bureau analysis.

So why do they happen?

Well first there are the politics of the situation.  Some CEO’s like to get close to celebrities or play golf with them. Others feel that it’s a big way to make a splash but for an industry so driven by ROI one would have to wonder just how the hell you tie ROI to a celebrity endorsement?

To me money is too damn tight today to waste dollars on celebrity endorsement and then have your market research people work overtime to justify the expense.  Most consumer marketers are starting to drop celebrities because they realize that it’s not the best use of marketing dollars that are too hard to come by today.

Richard Meyer is Executive Director/Principal at Online Strategic Solutions and blogs at World of DTC Marketing.com.

Submit a guest post and be heard on social media’s leading physician voice.

Prev

How a doctor learned how to suture

July 27, 2011 Kevin 0
…
Next

Implications of Nebraska’s ill-conceived fetal pain law

July 27, 2011 Kevin 7
…

Tagged as: Medications

Post navigation

< Previous Post
How a doctor learned how to suture
Next Post >
Implications of Nebraska’s ill-conceived fetal pain law

ADVERTISEMENT

More by Richard Meyer

  • 7 reasons why DTC drug marketing will decline in 2013

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    Mobile health apps don’t always follow conventional wisdom

    Richard Meyer
  • a desk with keyboard and ipad with the kevinmd logo

    How can pharma earn the trust of patients?

    Richard Meyer

More in Meds

  • How CAR-NK cancer therapy could be safer than CAR-T

    Cliff Dominy, PhD
  • Psychedelic-assisted therapy: science, safety, and regulation

    Muhamad Aly Rifai, MD
  • The anticoagulant evidence controversy: a whistleblower’s perspective

    David K. Cundiff, MD
  • Is tramadol really ineffective and risky?

    John A. Bumpus, PhD
  • Unregulated botanical products: the hidden risks of convenience store supplements

    Muhamad Aly Rifai, MD
  • “The meds made me do it”: Unpacking the Nick Reiner tragedy

    Arthur Lazarus, MD, MBA
  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Ghost networks in health care: Why physicians are suing insurers

      Timothy Lesaca, MD | Physician
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Focusing on outcomes over novelty prevents AI failure in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Why Brooklyn’s aging population needs more vascular health specialists

      Anil Hingorani, MD | Conditions
    • Escaping the golden cage of traditional medical practice to find joy again [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

Leave a Comment

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Will AI replace primary care physicians?

      P. Dileep Kumar, MD, MBA | Tech
    • Why every physician needs a sabbatical (and how to take one)

      Christie Mulholland, MD | Physician
    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Ghost networks in health care: Why physicians are suing insurers

      Timothy Lesaca, MD | Physician
  • Past 6 Months

    • Why patient trust in physicians is declining

      Mansi Kotwal, MD, MPH | Physician
    • Is primary care becoming a triage station?

      J. Leonard Lichtenfeld, MD | Physician
    • How environmental justice and health disparities connect to climate change

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Policy
    • A physician father on the Dobbs decision and reproductive rights

      Travis Walker, MD, MPH | Physician
    • The blind men and the elephant: a parable for modern pain management

      Richard A. Lawhern, PhD | Conditions
    • Is tramadol really ineffective and risky?

      John A. Bumpus, PhD | Meds
  • Recent Posts

    • Why the U.S. health care system is failing patients and physicians

      John C. Hagan III, MD | Policy
    • Focusing on outcomes over novelty prevents AI failure in health care [PODCAST]

      The Podcast by KevinMD | Podcast
    • What is the minority tax in medicine?

      Tharini Nagarkar and Maranda C. Ward, EdD, MPH | Education
    • Putting health back into insurance: the case for tobacco cessation

      Edward Anselm, MD | Policy
    • Why Brooklyn’s aging population needs more vascular health specialists

      Anil Hingorani, MD | Conditions
    • Escaping the golden cage of traditional medical practice to find joy again [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Leave a Comment

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...